Arkolith/Insider Trading/JSPR/Form 4

Mahal Jeetinder Singh

See RemarksJasper Therapeutics, Inc. (JSPR) · full profile →Form 4 · filed Jun 13, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$15K
Net Open-Market Flow
-$15K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 13, 2023Sell(S)9K$1.66$15K287K
Jun 13, 2023Option exercise(M)9K$0.71$6K296K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 13, 2023Option exercise(M)9K—$0174K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-23-048683) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML